Skip to main content
SpringerLink
Log in

Post-operative Replacement and Assessment of HPA Axis Recovery in Cushing’s Syndrome

  • Chapter
  • First Online:
Cushing's Syndrome

Part of the book series: Contemporary Endocrinology ((COE))

  • 2052 Accesses

Summary

The management of patients following surgery for pituitary, adrenal or ectopic Cushing’s syndrome is challenging, as adequate glucocorticoid replacement post-operatively is crucial to avoid hypoadrenalism. Following discharge from hospital, patients not only need to be seen regularly to assess for recurrence of Cushing’s syndrome but also to identify patients with recovery of the HPA axis. This chapter aims to give an overview of current opinions on how to assess Cushing’s patients following surgery and to offer guidelines on their treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kelly WF. Psychiatric aspects of Cushing’s syndrome. Q J Med 1996;89:543–551.

    Article  CAS  Google Scholar 

  2. Loosen PT. Psychiatric manifestations of Cushing’s syndrome. In: Blevins LS, ed. Cushing’s syndrome. Boston: Kluwer Academic Publishers, 2002:45–64.

    Chapter  Google Scholar 

  3. Utz A, Swearingen B, Biller B. Pituitary surgery and postoperative management in Cushing’s disease. Endocrinol Metab Clin North Am 2005;34:459–478.

    Article  PubMed  Google Scholar 

  4. Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 2003;88:5593–5602.

    Article  PubMed  CAS  Google Scholar 

  5. Mampalam TJ, Tyrell JB, Wilson CB. Transsphenoidal microsurgery for Cushing’s disease. Ann Int Med 1988;109:487–493.

    PubMed  CAS  Google Scholar 

  6. Invitti C, Giraldi FP, De Martin M, et al. Diagnosis and management of Cushing’s syndrome: results of an Italian multi-centre study. J Clin Endocrinol Metab 1999;84:440–448.

    Article  PubMed  CAS  Google Scholar 

  7. Bochicchio D, Losa M, Buchfelder M, and the European Cushing’s Disease Survey Study Group. Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 1995;80:3114–3120.

    Article  PubMed  CAS  Google Scholar 

  8. Rees DA, Hanna FWF, Davies JS, Mills RG, Vafidis J, Scanlon MF. Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single center using strict criteria for remission. Clin Endocrinol 2002;56:541–553.

    Article  CAS  Google Scholar 

  9. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM. Transsphenoidal resection in Cushing’s disease; undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 1993;38:73–78.

    Article  CAS  Google Scholar 

  10. Turner HE, Wass JAH. Oxford Handbook of Endocrinology and Diabetes. Oxford, UK, Oxford University Press, 2006;785.

    Google Scholar 

  11. Burke CW, Adams CBT, Esiri MM, Morris M, Bevan JS. Transsphenoidal surgery for Cushing’s disease: does what is removed determine the endocrine outcome? Clin Endocrinol 1990;33:525–537.

    Article  CAS  Google Scholar 

  12. McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, Atkinson AB. Assessment of endocrine function after transsphenoidal surgery for Cushing’s disease. Clin Endocrinol 1993;38:79–86.

    Article  CAS  Google Scholar 

  13. McCance DR, Besser M, Atkinson AB. Assessment of cure after transsphenoidal surgery for Cushing’s disease. Clin Endocrinol 1996;44:1–6.

    Article  CAS  Google Scholar 

  14. Toms GC, McCarthy MI, Niven MJ, Orteu CH, King TT, Monson JP. Predicting relapse after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 1993;76:291–294.

    Article  PubMed  CAS  Google Scholar 

  15. Pereira AM, van Aken MO, van Dulken H. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease. J Clin Endocrinol Metab 2003;88:5858.

    Article  PubMed  CAS  Google Scholar 

  16. Fitzgerald PA, Arnold DC, Findling JW. Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab 1982;54:413–422.

    Article  PubMed  CAS  Google Scholar 

  17. Inder WJ, Hunt PJ. Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management. J Clin Endocrinol Metab 2002;87:2745–2750.

    Article  PubMed  CAS  Google Scholar 

  18. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, Cordon-Cardo C, Jacques DP, Brennan MF. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002;20:941–950.

    Article  PubMed  CAS  Google Scholar 

  19. Orth DN. Corticotropin-releasing hormone in humans. Endocr Rev 1992;13:164.

    PubMed  CAS  Google Scholar 

  20. Aniszewski JP, Young WF, Thompson GB. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg 2001;25:934.

    Article  PubMed  CAS  Google Scholar 

  21. Ilias I, Torpy DJ, Pacak K. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years experience at the National Institute of Health. J Clin Endocrinol Metab 2005;90:4955.

    Article  PubMed  CAS  Google Scholar 

  22. Sidori AM, Kaltsas GA, Pozza C. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management and long-term follow-up. J Clin Endocrinol Metab 2006;91:371.

    Article  Google Scholar 

  23. Semple CG, Thomson JA, Teasdale GM. Transsphenoidal microsurgery for Cushing’s disease. Clin Endocrinol 1984;21:621–629.

    Article  CAS  Google Scholar 

  24. McKenna TJ. Perioperative Evaluation and Management. Cushing’s syndrome. Boston, Kluwer Academic Publishers, 2002; 279–299.

    Google Scholar 

  25. Lamberts SW, De Herder WW, Van der Lely AJ. Pituitary insufficiency. Lancet 1998;352:127–134.

    PubMed  CAS  Google Scholar 

  26. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995–2010.

    Article  PubMed  CAS  Google Scholar 

  27. Bhasin S. Approach to the infertile man. J Clin Endocrinol Metab 2007;92:1995–2004.

    Article  PubMed  CAS  Google Scholar 

  28. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, et al. Hypopituitarism. Lancet 2007;369:1461–1470.

    Article  PubMed  CAS  Google Scholar 

  29. Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, et al. Successful treatment of childhood-onset Cushing’s disease is associated with persistent reduction in growth hormone secretion. Clin Endocrinol 2004;60:169–174.

    Article  CAS  Google Scholar 

  30. Hughes NR, Lisset CA, Shalet SM. Growth hormone status following treatment for Cushing’s syndrome. Clin Endocrinol 1999;51:61–66.

    Article  CAS  Google Scholar 

  31. Tzanela M, Karavitaki N, Stylianidou C, Tsagarakis S, Thalassinos NC. Assessment of GH reserve before and after successful treatment of adult patients with Cushing’s syndrome. Clin Endocrinol 2004;60:309–314.

    Article  CAS  Google Scholar 

  32. Nemergut E, Dumont A, Barry U, Laws E. Perioperative management of patients undergoing transsphenoidal pituitary surgery. Anesth Analg 2005;101:1170–1181.

    Article  PubMed  Google Scholar 

  33. Ausiello JC, Bruce JN, Freda P. Postoperative assessment of the patient after transsphenoidal pituitary surgery. Pituitary 2008;11(4):391–401.

    Article  PubMed  Google Scholar 

  34. Dumont AS, Nemergut EC, Jane JA, Jr, Laws ER, Jr. Postoperative care following pituitary surgery. J Intensive Care Med 2005;20:127–140.

    Article  PubMed  Google Scholar 

  35. Yap LB, Turner HE, Adams CB, Wass JAH. Undetectable postoperative cortisol does not always predict long-term remission in Cushing’s disease: a single centre audit. Clin Endocrinol 2002;56:25–31.

    Article  CAS  Google Scholar 

  36. Rollin GAFS, Ferreira NP, Junges M. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing’s disease. J Clin Endocrinol Metab 2004;89:1131–1139.

    Article  PubMed  CAS  Google Scholar 

  37. Estrada J, Garcia-Uria JL, Lamas C. The complete normalisation of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 2001;86:5695–5699.

    Article  PubMed  CAS  Google Scholar 

  38. Eberwine JH, Roberts JL. Analysis of pro-opiomelanocortin gene structure and function. DNA 1983;2:1–8.

    Article  PubMed  CAS  Google Scholar 

  39. Salenave S, Gatta B, Pecheur S, et al. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocortitropin-secreting microadenomas. J Clin Endocrinol Metab 2004;89: 3371–3376.

    Article  PubMed  CAS  Google Scholar 

  40. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E. Transsphenoidal pituitary surgery for the treatment of Cushing’s disease: results in 64 patients and long-term follow-up studies. J Clin Endocrinol Metab 1988;66:1056–1064.

    Article  PubMed  CAS  Google Scholar 

  41. Hammer GD, Tyrrell JB, Lamborn KR. Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results. J Clin Endocrinol Metab 2004;89:6348–6357.

    Article  PubMed  CAS  Google Scholar 

  42. Blevins LSJ, Christy JH, Khajavi M. Outcomes of therapy for Cushing’s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 1998;83:63–67.

    Article  PubMed  CAS  Google Scholar 

  43. Cannavo S, Almoto B, Dall’Asta C. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur J Endocrinol 2003;149:195–200.

    Article  PubMed  CAS  Google Scholar 

  44. Chee GH, Mathias DB, James RA. Transsphenoidal pituitary surgery in Cushing’s disease: can we predict outcome? Clin Endocrinol 2001;54:617–626.

    Article  CAS  Google Scholar 

  45. Booth GL, Redelmeier DA, Grosman H. Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing’s disease. J Clin Endocrinol Metab 1998;83:2291–2295.

    Article  PubMed  CAS  Google Scholar 

  46. Pieters GFFM, Hermus ARMM, Meijer E. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing’s disease. J Clin Endocrinol Metab 1989;69:1122–1126.

    Article  PubMed  CAS  Google Scholar 

  47. Graham KE, Samuels MH, Raff H. Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing’s disease do not predict cure. J Clin Endocrinol Metab 1997;82:1776.

    Article  PubMed  CAS  Google Scholar 

  48. Baudin E, Pellegriti G, Bonnay M, Penfornis A, Laplanche A, Vassal G, Schlumberger M. Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p′DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer 2001;92:1385–1392.

    Article  PubMed  CAS  Google Scholar 

  49. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat MH, Louvel A, Chapuis Y, Blondeau P, Bonnin A, Bricaire H. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195–1201.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, 0X37LJ, UK

    Sibylle Kohler MD, Niki Karavitaki MD & John A. H. Wass MD

Authors
  1. Sibylle Kohler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niki Karavitaki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John A. H. Wass MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Division of Endocrinology and Metabolism, Hospital das Clínicas, University of Sao, Sao Paulo, 05403-000, Brazil

    Marcello D. Bronstein

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kohler, S., Karavitaki, N., Wass, J.A.H. (2010). Post-operative Replacement and Assessment of HPA Axis Recovery in Cushing’s Syndrome. In: Bronstein, M. (eds) Cushing's Syndrome. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-449-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-449-4_20

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-448-7

  • Online ISBN: 978-1-60327-449-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation